{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T01:24:58Z","timestamp":1793496298672,"version":"4.5.0"},"reference-count":100,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2021,2,19]],"date-time":"2021-02-19T00:00:00Z","timestamp":1613692800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K08CA241365"],"award-info":[{"award-number":["K08CA241365"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,3,20]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Accurate and individualized breast cancer risk assessment can be used to guide personalized screening and prevention recommendations. Existing risk prediction models use genetic and nongenetic risk factors to provide an estimate of a woman\u2019s breast cancer risk and\/or the likelihood that she has a BRCA1 or BRCA2 mutation. Each model is best suited for specific clinical scenarios and may have limited applicability in certain types of patients. For example, the Breast Cancer Risk Assessment Tool, which identifies women who would benefit from chemoprevention, is readily accessible and user-friendly but cannot be used in women under 35 years of age or those with prior breast cancer or lobular carcinoma in situ. Emerging research on deep learning-based artificial intelligence (AI) models suggests that mammographic images contain risk indicators that could be used to strengthen existing risk prediction models. This article reviews breast cancer risk factors, describes the appropriate use, strengths, and limitations of each risk prediction model, and discusses the emerging role of AI for risk assessment.<\/jats:p>","DOI":"10.1093\/jbi\/wbab001","type":"journal-article","created":{"date-parts":[[2021,2,20]],"date-time":"2021-02-20T23:14:51Z","timestamp":1613862891000},"page":"144-155","source":"Crossref","is-referenced-by-count":113,"title":["Assessing Risk of Breast Cancer: A Review of Risk Prediction Models"],"prefix":"10.1093","volume":"3","author":[{"given":"Geunwon","family":"Kim","sequence":"first","affiliation":[{"name":"Beth Israel Deaconess Medical Center, Department of Radiology, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manisha","family":"Bahl","sequence":"additional","affiliation":[{"name":"Massachusetts General Hospital, Department of Radiology, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,2,19]]},"reference":[{"issue":"19","key":"2021032014543320800_CIT0001","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1002\/cncr.28771","article-title":"Breast cancer screening in an era of personalized regimens: a conceptual model and National Cancer Institute initiative for risk-based and preference-based approaches at a population level","volume":"120","author":"Onega","year":"2014","journal-title":"Cancer"},{"issue":"2","key":"2021032014543320800_CIT0002","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3322\/canjclin.57.2.75","article-title":"American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography","volume":"57","author":"Saslow","year":"2007","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"2021032014543320800_CIT0003","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.jacr.2017.11.034","article-title":"Breast cancer screening in women at higher-than-average risk: recommendations from the ACR","volume":"15","author":"Monticciolo","year":"2018","journal-title":"J Am Coll Radiol"},{"issue":"22","key":"2021032014543320800_CIT0004","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1056\/NEJMoa1903986","article-title":"Supplemental MRI screening for women with extremely dense breast tissue","volume":"381","author":"Bakker","year":"2019","journal-title":"N Engl J Med"},{"issue":"1","key":"2021032014543320800_CIT0005","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.rcl.2020.09.006","article-title":"Supplemental screening for patients at intermediate and high risk for breast cancer","volume":"59","author":"Wang","year":"2021","journal-title":"Radiol Clin North Am"},{"issue":"2","key":"2021032014543320800_CIT0006","doi-asserted-by":"crossref","first-page":"284","DOI":"10.2214\/AJR.16.17205","article-title":"Abbreviated MRI protocols: wave of the future for breast cancer screening","volume":"208","author":"Chhor","year":"2017","journal-title":"AJR Am J Roentgenol"},{"issue":"5","key":"2021032014543320800_CIT0007","doi-asserted-by":"crossref","first-page":"W267","DOI":"10.2214\/AJR.17.19355","article-title":"Contrast-enhanced spectral mammography in women with intermediate breast cancer risk and dense breasts","volume":"211","author":"Sorin","year":"2018","journal-title":"AJR Am J Roentgenol"},{"issue":"23","key":"2021032014543320800_CIT0008","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1200\/JCO.2013.49.3122","article-title":"Use of pharmacologic interventions for breast cancer risk reduction: American Society of Clinical Oncology clinical practice guideline","volume":"31","author":"Visvanathan","year":"2013","journal-title":"J Clin Oncol"},{"issue":"4","key":"2021032014543320800_CIT0009","doi-asserted-by":"crossref","first-page":"268","DOI":"10.7326\/M15-1789","article-title":"Supplemental screening for breast cancer in women with dense breasts: a systematic review for the U.S. Preventive Services Task Force","volume":"164","author":"Melnikow","year":"2016","journal-title":"Ann Intern Med"},{"issue":"10","key":"2021032014543320800_CIT0010","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1093\/jnci\/djq088","article-title":"Assessing women at high risk of breast cancer: a review of risk assessment models","volume":"102","author":"Amir","year":"2010","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"2021032014543320800_CIT0011","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1148\/radiol.2019192471","volume":"294","author":"Bahl","year":"2020","journal-title":"Radiology"},{"issue":"9","key":"2021032014543320800_CIT0012","doi-asserted-by":"crossref","first-page":"635","DOI":"10.7326\/0003-4819-156-9-201205010-00006","article-title":"Risk factors for breast cancer for women aged 40 to 49 years: a systematic review and meta-analysis","volume":"156","author":"Nelson","year":"2012","journal-title":"Ann Intern Med"},{"issue":"3","key":"2021032014543320800_CIT0013","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.soc.2014.03.011","article-title":"Epidemiology of breast cancer","volume":"23","author":"Ban","year":"2014","journal-title":"Surg Oncol Clin N Am"},{"issue":"5","key":"2021032014543320800_CIT0014","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/bcr1750","article-title":"Breast cancer risk-assessment models","volume":"9","author":"Evans","year":"2007","journal-title":"Breast Cancer Res"},{"issue":"6","key":"2021032014543320800_CIT0015","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1056\/NEJMoa0807684","article-title":"Breast cancer after use of estrogen plus progestin in postmenopausal women","volume":"360","author":"Chlebowski","year":"2009","journal-title":"N Engl J Med"},{"issue":"4","key":"2021032014543320800_CIT0016","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1097\/01.SLA.0000059969.64262.87","article-title":"Rating the risk factors for breast cancer","volume":"237","author":"Singletary","year":"2003","journal-title":"Ann Surg"},{"issue":"1","key":"2021032014543320800_CIT0017","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1148\/radiol.2301020870","article-title":"Quantitative assessment of mammographic breast density: relationship with breast cancer risk","volume":"230","author":"Harvey","year":"2004","journal-title":"Radiology"},{"issue":"6","key":"2021032014543320800_CIT0018","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1158\/1055-9965.EPI-06-0034","article-title":"Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis","volume":"15","author":"McCormack","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"9","key":"2021032014543320800_CIT0019","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1001\/jamaoncol.2016.6326","article-title":"Population-attributable risk proportion of clinical risk factors for breast cancer","volume":"3","author":"Engmann","year":"2017","journal-title":"JAMA Oncol"},{"issue":"4","key":"2021032014543320800_CIT0020","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.mcna.2017.03.005","article-title":"Risk-based breast cancer screening: implications of breast density","volume":"101","author":"Lee","year":"2017","journal-title":"Med Clin North Am"},{"issue":"17","key":"2021032014543320800_CIT0021","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1093\/jnci\/djj332","article-title":"Projecting absolute invasive breast cancer risk in white women with a model that includes mammographic density","volume":"98","author":"Chen","year":"2006","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"2021032014543320800_CIT0022","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s13058-015-0653-5","article-title":"Mammographic density adds accuracy to both the Tyrer-Cuzick and Gail breast cancer risk models in a prospective UK screening cohort","volume":"17","author":"Brentnall","year":"2015","journal-title":"Breast Cancer Res"},{"issue":"9","key":"2021032014543320800_CIT0023","doi-asserted-by":"crossref","first-page":"e180174","DOI":"10.1001\/jamaoncol.2018.0174","article-title":"Long-term accuracy of breast cancer risk assessment combining classic risk factors and breast density","volume":"4","author":"Brentnall","year":"2018","journal-title":"JAMA Oncol"},{"issue":"2","key":"2021032014543320800_CIT0024","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1093\/jbi\/wbz006","article-title":"A case-control study to add volumetric or clinical mammographic density into the Tyrer-Cuzick breast cancer risk model","volume":"1","author":"Brentnall","year":"2019","journal-title":"J Breast Imag"},{"key":"2021032014543320800_CIT0025","doi-asserted-by":"crossref","first-page":"109019","DOI":"10.1016\/j.ejrad.2020.109019","article-title":"Impact of adding breast density to breast cancer risk models: a systematic review","volume":"127","author":"Vilmun","year":"2020","journal-title":"Eur J Radiol"},{"issue":"1","key":"2021032014543320800_CIT0026","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/ng.2007.53","article-title":"The emerging landscape of breast cancer susceptibility","volume":"40","author":"Stratton","year":"2008","journal-title":"Nat Genet"},{"issue":"7678","key":"2021032014543320800_CIT0027","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/nature24284","article-title":"Association analysis identifies 65 new breast cancer risk loci","volume":"551","author":"Michailidou","year":"2017","journal-title":"Nature"},{"issue":"7","key":"2021032014543320800_CIT0028","doi-asserted-by":"crossref","first-page":"e208501","DOI":"10.1001\/jamanetworkopen.2020.8501","article-title":"Association of a polygenic risk score with breast cancer among women carriers of high- and moderate-risk breast cancer genes","volume":"3","author":"Gallagher","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"3","key":"2021032014543320800_CIT0029","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1056\/NEJM198501173120303","article-title":"Risk factors for breast cancer in women with proliferative breast disease","volume":"312","author":"Dupont","year":"1985","journal-title":"N Engl J Med"},{"issue":"3","key":"2021032014543320800_CIT0030","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJMoa044383","article-title":"Benign breast disease and the risk of breast cancer","volume":"353","author":"Hartmann","year":"2005","journal-title":"N Engl J Med"},{"issue":"19","key":"2021032014543320800_CIT0031","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1093\/jnci\/dji290","article-title":"Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma","volume":"97","author":"Travis","year":"2005","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"2021032014543320800_CIT0032","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1093\/jnci\/87.3.190","article-title":"A prospective study of endogenous estrogens and breast cancer in postmenopausal women","volume":"87","author":"Toniolo","year":"1995","journal-title":"J Natl Cancer Inst"},{"issue":"11","key":"2021032014543320800_CIT0033","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1093\/jnci\/88.11.756","article-title":"Reversal of relation between body mass and endogenous estrogen concentrations with menopausal status","volume":"88","author":"Potischman","year":"1996","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"2021032014543320800_CIT0034","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1249\/MSS.0000000000001937","article-title":"Physical activity in cancer prevention and survival: a systematic review","volume":"51","author":"McTiernan","year":"2019","journal-title":"Med Sci Sports Exerc"},{"issue":"1","key":"2021032014543320800_CIT0035","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jacr.2009.09.022","article-title":"Breast cancer screening with imaging: recommendations from the Society of Breast Imaging and the ACR on the use of mammography, breast MRI, breast ultrasound, and other technologies for the detection of clinically occult breast cancer","volume":"7","author":"Lee","year":"2010","journal-title":"J Am Coll Radiol"},{"key":"2021032014543320800_CIT0036","article-title":"Potential of using mammography screening appointments to identify high-risk women: cross sectional survey results from the national health interview survey [published online ahead of print November 12, 2020]","author":"Narayan","year":"2020","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"2021032014543320800_CIT0037","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.rcl.2016.12.013","article-title":"Breast cancer risk assessment models and high-risk screening","volume":"55","author":"Barke","year":"2017","journal-title":"Radiol Clin North Am"},{"issue":"7","key":"2021032014543320800_CIT0038","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1001\/jama.2019.10987","article-title":"Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer: US Preventive Services Task Force recommendation statement","volume":"322","author":"Owens","year":"2019","journal-title":"JAMA"},{"issue":"4","key":"2021032014543320800_CIT0039","doi-asserted-by":"crossref","first-page":"380","DOI":"10.6004\/jnccn.2020.0017","article-title":"NCCN guidelines insights: genetic\/familial high-risk assessment: breast, ovarian, and pancreatic, version 1.2020","volume":"18","author":"Daly","year":"2020","journal-title":"J Natl Compr Canc Netw"},{"issue":"1","key":"2021032014543320800_CIT0040","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1214\/19-STS729","article-title":"Risk models for breast cancer and their validation","volume":"35","author":"Brentnall","year":"2020","journal-title":"Stat Sci"},{"issue":"2","key":"2021032014543320800_CIT0041","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s10549-011-1818-2","article-title":"A systematic review of breast cancer incidence risk prediction models with meta-analysis of their performance","volume":"132","author":"Meads","year":"2012","journal-title":"Breast Cancer Res Treat"},{"issue":"24","key":"2021032014543320800_CIT0042","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1093\/jnci\/81.24.1879","article-title":"Projecting individualized probabilities of developing breast cancer for white females who are being examined annually","volume":"81","author":"Gail","year":"1989","journal-title":"J Natl Cancer Inst"},{"issue":"18","key":"2021032014543320800_CIT0043","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1093\/jnci\/91.18.1541","article-title":"Validation studies for models projecting the risk of invasive and total breast cancer incidence","volume":"91","author":"Costantino","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"2021032014543320800_CIT0044","author":"National Cancer Institute (NCI)"},{"issue":"5","key":"2021032014543320800_CIT0045","doi-asserted-by":"crossref","first-page":"337","DOI":"10.7326\/0003-4819-148-5-200803040-00004","article-title":"Using clinical factors and mammographic breast density to estimate breast cancer risk: development and validation of a new predictive model","volume":"148","author":"Tice","year":"2008","journal-title":"Ann Intern Med"},{"key":"2021032014543320800_CIT0046","author":"Breast Cancer Surveillance Consortium (BCSC)"},{"issue":"5","key":"2021032014543320800_CIT0047","doi-asserted-by":"crossref","first-page":"dju397","DOI":"10.1093\/jnci\/dju397","article-title":"The contributions of breast density and common genetic variation to breast cancer risk","volume":"107","author":"Vachon","year":"2015","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"2021032014543320800_CIT0048","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s10549-019-05167-2","article-title":"Validation of the breast cancer surveillance consortium model of breast cancer risk","volume":"175","author":"Tice","year":"2019","journal-title":"Breast Cancer Res Treat"},{"issue":"28","key":"2021032014543320800_CIT0049","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1200\/JCO.2015.60.8869","article-title":"Breast density and benign breast disease: risk assessment to identify women at high risk of breast cancer","volume":"33","author":"Tice","year":"2015","journal-title":"J Clin Oncol"},{"issue":"1","key":"2021032014543320800_CIT0050","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s13058-017-0887-5","article-title":"Combining quantitative and qualitative breast density measures to assess breast cancer risk","volume":"19","author":"Kerlikowske","year":"2017","journal-title":"Breast Cancer Res"},{"issue":"6","key":"2021032014543320800_CIT0051","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1093\/jnci\/88.6.359","article-title":"Nurses\u2019 health study: log-incidence mathematical model of breast cancer incidence","volume":"88","author":"Rosner","year":"1996","journal-title":"J Natl Cancer Inst"},{"issue":"9","key":"2021032014543320800_CIT0052","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/S0895-4356(03)00124-0","article-title":"Breast cancer risk prediction with a log-incidence model: evaluation of accuracy","volume":"56","author":"Rockhill","year":"2003","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"2021032014543320800_CIT0053","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s10549-013-2719-3","article-title":"Validation of Rosner-Colditz breast cancer incidence model using an independent data set, the California Teachers Study","volume":"142","author":"Rosner","year":"2013","journal-title":"Breast Cancer Res Treat"},{"issue":"7","key":"2021032014543320800_CIT0054","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1200\/JCO.2016.69.8944","article-title":"Impact of a panel of 88 single nucleotide polymorphisms on the risk of breast cancer in high-risk women: results from two randomized Tamoxifen prevention trials","volume":"35","author":"Cuzick","year":"2017","journal-title":"J Clin Oncol"},{"issue":"4","key":"2021032014543320800_CIT0055","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/S1470-2045(18)30902-1","article-title":"10-year performance of four models of breast cancer risk: a validation study","volume":"20","author":"Terry","year":"2019","journal-title":"Lancet Oncol"},{"issue":"7","key":"2021032014543320800_CIT0056","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1002\/sim.1668","article-title":"A breast cancer prediction model incorporating familial and personal risk factors","volume":"23","author":"Tyrer","year":"2004","journal-title":"Stat Med"},{"issue":"3","key":"2021032014543320800_CIT0057","doi-asserted-by":"crossref","first-page":"355","DOI":"10.2217\/fon.10.5","article-title":"Clinical application of breast cancer risk assessment models","volume":"6","author":"Ready","year":"2010","journal-title":"Future Oncol"},{"issue":"6","key":"2021032014543320800_CIT0058","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1136\/jmedgenet-2012-101415","article-title":"Evaluating the performance of the breast cancer genetic risk models BOADICEA, IBIS, BRCAPRO and Claus for predicting BRCA1\/2 mutation carrier probabilities: a study based on 7352 families from the German Hereditary Breast and Ovarian Cancer Consortium","volume":"50","author":"Fischer","year":"2013","journal-title":"J Med Genet"},{"issue":"11","key":"2021032014543320800_CIT0059","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1136\/jmg.40.11.807","article-title":"Evaluation of breast cancer risk assessment packages in the family history evaluation and screening programme","volume":"40","author":"Amir","year":"2003","journal-title":"J Med Genet"},{"issue":"3","key":"2021032014543320800_CIT0060","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1093\/jnci\/89.3.227","article-title":"Probability of carrying a mutation of breast-ovarian cancer gene BRCA1 based on family history","volume":"89","author":"Berry","year":"1997","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"2021032014543320800_CIT0061","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1086\/301670","article-title":"Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2","volume":"62","author":"Parmigiani","year":"1998","journal-title":"Am J Hum Genet"},{"issue":"7","key":"2021032014543320800_CIT0062","doi-asserted-by":"crossref","first-page":"441","DOI":"10.7326\/0003-4819-147-7-200710020-00002","article-title":"Validity of models for predicting BRCA1 and BRCA2 mutations","volume":"147","author":"Parmigiani","year":"2007","journal-title":"Ann Intern Med"},{"issue":"1","key":"2021032014543320800_CIT0063","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s10549-012-1958-z","article-title":"Assessing the added value of breast tumor markers in genetic risk prediction model BRCAPRO","volume":"133","author":"Biswas","year":"2012","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"2021032014543320800_CIT0064","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/sj.bjc.6600008","article-title":"A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes","volume":"86","author":"Antoniou","year":"2002","journal-title":"Br J Cancer"},{"issue":"8","key":"2021032014543320800_CIT0065","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1038\/sj.bjc.6604305","article-title":"The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions","volume":"98","author":"Antoniou","year":"2008","journal-title":"Br J Cancer"},{"issue":"2","key":"2021032014543320800_CIT0066","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/bjc.2013.730","article-title":"BOADICEA breast cancer risk prediction model: updates to cancer incidences, tumour pathology and web interface","volume":"110","author":"Lee","year":"2014","journal-title":"Br J Cancer"},{"issue":"2","key":"2021032014543320800_CIT0067","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s10549-017-4247-z","article-title":"Breast cancer risk models: a comprehensive overview of existing models, validation, and clinical applications","volume":"164","author":"Cintolo-Gonzalez","year":"2017","journal-title":"Breast Cancer Res Treat"},{"issue":"15","key":"2021032014543320800_CIT0068","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1001\/jama.1997.03550150046034","article-title":"BRCA1 sequence analysis in women at high risk for susceptibility mutations. Risk factor analysis and implications for genetic testing","volume":"278","author":"Shattuck-Eidens","year":"1997","journal-title":"JAMA"},{"issue":"7","key":"2021032014543320800_CIT0069","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1200\/JCO.1998.16.7.2417","article-title":"Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk","volume":"16","author":"Frank","year":"1998","journal-title":"J Clin Oncol"},{"issue":"6","key":"2021032014543320800_CIT0070","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1200\/JCO.2002.20.6.1480","article-title":"Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals","volume":"20","author":"Frank","year":"2002","journal-title":"J Clin Oncol"},{"key":"2021032014543320800_CIT0071","author":"Myriad"},{"issue":"4","key":"2021032014543320800_CIT0072","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s10689-007-9150-z","article-title":"Predicting BRCA1 and BRCA2 gene mutation carriers: comparison of LAMBDA, BRCAPRO, Myriad II, and modified Couch models","volume":"6","author":"Lindor","year":"2007","journal-title":"Fam Cancer"},{"issue":"7","key":"2021032014543320800_CIT0073","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1136\/jmg.2007.056556","article-title":"Predicting the likelihood of carrying a BRCA1 or BRCA2 mutation: validation of BOADICEA, BRCAPRO, IBIS, Myriad and the Manchester scoring system using data from UK genetics clinics","volume":"45","author":"Antoniou","year":"2008","journal-title":"J Med Genet"},{"key":"2021032014543320800_CIT0074","doi-asserted-by":"crossref","DOI":"10.1002\/0471722146","volume-title":"Applied Logistic Regression","author":"Hosmer","year":"2000","edition":"2nd ed"},{"key":"2021032014543320800_CIT0075","author":"NCCN Clinical Practice Guidelines in Oncology"},{"issue":"5","key":"2021032014543320800_CIT0076","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1093\/jnci\/93.5.358","article-title":"Validation of the Gail","volume":"93","author":"Rockhill","year":"2001","journal-title":"J Natl Cancer Inst"},{"issue":"23","key":"2021032014543320800_CIT0077","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1093\/jnci\/djm223","article-title":"Projecting individualized absolute invasive breast cancer risk in African American women","volume":"99","author":"Gail","year":"2007","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"2021032014543320800_CIT0078","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1158\/1055-9965.EPI-15-0035","article-title":"One versus two breast density measures to predict 5- and 10-year breast cancer risk","volume":"24","author":"Kerlikowske","year":"2015","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"3","key":"2021032014543320800_CIT0079","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s10549-016-3953-2","article-title":"Breast cancer risk prediction using a clinical risk model and polygenic risk score","volume":"159","author":"Shieh","year":"2016","journal-title":"Breast Cancer Res Treat"},{"issue":"5920","key":"2021032014543320800_CIT0080","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/303767a0","article-title":"\u2018Hormonal\u2019 risk factors, \u2018breast tissue age\u2019 and the age-incidence of breast cancer","volume":"303","author":"Pike","year":"1983","journal-title":"Nature"},{"issue":"3","key":"2021032014543320800_CIT0081","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/bcr1029","article-title":"The protective role of pregnancy in breast cancer","volume":"7","author":"Russo","year":"2005","journal-title":"Breast Cancer Res"},{"issue":"10","key":"2021032014543320800_CIT0082","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1093\/aje\/152.10.950","article-title":"Cumulative risk of breast cancer to age 70 years according to risk factor status: data from the Nurses\u2019 Health Study","volume":"152","author":"Colditz","year":"2000","journal-title":"Am J Epidemiol"},{"issue":"1","key":"2021032014543320800_CIT0083","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s10549-017-4391-5","article-title":"Breast cancer risk prediction: an update to the Rosner-Colditz breast cancer incidence model","volume":"166","author":"Rice","year":"2017","journal-title":"Breast Cancer Res Treat"},{"issue":"8","key":"2021032014543320800_CIT0084","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1002\/ijc.32541","article-title":"A case-control evaluation of 143 single nucleotide polymorphisms for breast cancer risk stratification with classical factors and mammographic density","volume":"146","author":"Brentnall","year":"2020","journal-title":"Int J Cancer"},{"issue":"2","key":"2021032014543320800_CIT0085","first-page":"232","article-title":"Genetic analysis of breast cancer in the cancer and steroid hormone study","volume":"48","author":"Claus","year":"1991","journal-title":"Am J Hum Genet"},{"issue":"3","key":"2021032014543320800_CIT0086","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/1097-0142(19940201)73:3<643::AID-CNCR2820730323>3.0.CO;2-5","article-title":"Autosomal dominant inheritance of early-onset breast cancer. Implications for risk prediction","volume":"73","author":"Claus","year":"1994","journal-title":"Cancer"},{"issue":"2","key":"2021032014543320800_CIT0087","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/BF00666424","article-title":"The calculation of breast cancer risk for women with a first degree family history of ovarian cancer","volume":"28","author":"Claus","year":"1993","journal-title":"Breast Cancer Res Treat"},{"issue":"4","key":"2021032014543320800_CIT0088","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1023\/A:1008396129543","article-title":"A comparison of methods currently used in clinical practice to estimate familial breast cancer risks","volume":"11","author":"Tischkowitz","year":"2000","journal-title":"Ann Oncol"},{"issue":"11","key":"2021032014543320800_CIT0089","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1200\/JCO.2002.05.121","article-title":"BRCAPRO validation, sensitivity of genetic testing of BRCA1\/BRCA2, and prevalence of other breast cancer susceptibility genes","volume":"20","author":"Berry","year":"2002","journal-title":"J Clin Oncol"},{"key":"2021032014543320800_CIT0090","first-page":"147","article-title":"Recent enhancements to the genetic risk prediction model BRCAPRO","volume":"14","author":"Mazzola","year":"2015","journal-title":"Cancer Inform"},{"key":"2021032014543320800_CIT0091","doi-asserted-by":"crossref","DOI":"10.2202\/1544-6115.1063","article-title":"BayesMendel: an R environment for Mendelian risk prediction","author":"Chen","year":"2004","journal-title":"Stat Appl Genet Mol Biol"},{"issue":"1","key":"2021032014543320800_CIT0092","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s10549-013-2605-z","article-title":"Providing access to risk prediction tools via the HL7 XML-formatted risk web service","volume":"140","author":"Chipman","year":"2013","journal-title":"Breast Cancer Res Treat"},{"key":"2021032014543320800_CIT0093","author":"UT Southwestern Medical Center at Dallas and The BayesMendel Group"},{"issue":"12","key":"2021032014543320800_CIT0094","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1038\/gim.2016.31","article-title":"Incorporating truncating variants in PALB2, CHEK2, and ATM into the BOADICEA breast cancer risk model","volume":"18","author":"Lee","year":"2016","journal-title":"Genet Med"},{"issue":"11","key":"2021032014543320800_CIT0095","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1093\/jnci\/91.11.943","article-title":"Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer","volume":"91","author":"Peto","year":"1999","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"2021032014543320800_CIT0096","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/gepi.1014","article-title":"Evidence for further breast cancer susceptibility genes in addition to BRCA1 and BRCA2 in a population-based study","volume":"21","author":"Antoniou","year":"2001","journal-title":"Genet Epidemiol"},{"issue":"5","key":"2021032014543320800_CIT0097","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1086\/375033","article-title":"Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies","volume":"72","author":"Antoniou","year":"2003","journal-title":"Am J Hum Genet"},{"issue":"8","key":"2021032014543320800_CIT0098","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1038\/s41436-018-0406-9","article-title":"BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors","volume":"21","author":"Lee","year":"2019","journal-title":"Genet Med"},{"issue":"2","key":"2021032014543320800_CIT0099","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1148\/radiol.2019190872","article-title":"Comparison of a deep learning risk score and standard mammographic density score for breast cancer risk prediction","volume":"294","author":"Dembrower","year":"2020","journal-title":"Radiology"},{"issue":"1","key":"2021032014543320800_CIT0100","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1148\/radiol.2019182716","article-title":"A deep learning mammography-based model for improved breast cancer risk prediction","volume":"292","author":"Yala","year":"2019","journal-title":"Radiology"}],"container-title":["Journal of Breast Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jbi\/article-pdf\/3\/2\/144\/36648770\/wbab001.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jbi\/article-pdf\/3\/2\/144\/36648770\/wbab001.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,20]],"date-time":"2021-03-20T10:55:53Z","timestamp":1616237753000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbi\/article\/3\/2\/144\/6144904"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,19]]},"references-count":100,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,2,19]]},"published-print":{"date-parts":[[2021,3,20]]}},"URL":"https:\/\/doi.org\/10.1093\/jbi\/wbab001","relation":{},"ISSN":["2631-6110","2631-6129"],"issn-type":[{"value":"2631-6110","type":"print"},{"value":"2631-6129","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,3,1]]},"published":{"date-parts":[[2021,2,19]]}}}